Tumor treating fields (TTFields): A novel treatment modality added to standard chemo- and radiotherapy in newly diagnosed glioblastoma—First report of the full dataset of the EF14 randomized phase III trial.-Reference-Cited by-同舟云学术

Tumor treating fields (TTFields): A novel treatment modality added to standard chemo- and radiotherapy in newly diagnosed glioblastoma—First report of the full dataset of the EF14 randomized phase III trial.

Published:2015-05-20 Issue:15_suppl Volume:33 Page:2000-2000
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Stupp Roger¹,Taillibert Sophie²,Kanner Andrew³,Kesari Santosh⁴,Toms Steven A⁵,Barnett Gene H.⁶,Fink Karen L.⁷,Silvani Antonio⁸,Lieberman Frank S.⁹,Zhu Jay-Jiguang¹⁰,Taylor Lynne Patricia¹¹,Honnorat Jerôme¹²,Hottinger Andreas¹³,Chen Thomas¹⁴,Tran David Dinh¹⁵,Kim Chae-yong¹⁶,Hirte Hal W.¹⁷,Hegi Monika E.¹⁸,Palti Yoram¹⁹,Ram Zvi²⁰

Affiliation:

1. University Hospital Zurich & University of Zurich, Zurich, Switzerland

2. Hopital Pitie-Salpetriere, Paris, France

3. Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

4. UC San Diego, La Jolla, CA

5. Geisinger Health System, Danville, PA

6. Cleveland Clinic Foundation, Cleveland, OH

7. Baylor Research Institute, Dallas, TX

8. Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

9. University of Pittsburgh, Pittsburgh, PA

10. The University of Texas Medical School at Houston, Houston, TX

11. Tufts Medical Center, Boston, MA